Based on 5 analysts giving stock ratings to vTv Therapeutics Inc in the past month.
In the current month, VTVT has received 4 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. VTVT average Analyst price target in the last month is 56.000.
Based on analysts' estimates, VTVT EPS is projected to reach -1.268 in FY2026Q4, following reported EPS of -0.935 in FY2026Q3. Track earnings expectations against reported figures to see how profitability is evolving.
The market expectation was USD -0.94, while vTv Therapeutics IncVTVT's earnings per share (EPS) for the previous quarter was USD -1.05. EPS for the next quarter is expected at USD -1.27.